Nuclear receptors form a superfamily of proteins that function as ligand-activated transcription factors. One class of these receptors is hormone receptors to which steroid/thyroid hormones/retinoid bind, and thus is involved in endocrine system disorders, such as breast and prostate cancer. Another class of receptors was called orphan receptors because their ligands were unknown. Recently, the ligands were identified for some of these receptors, revealing their functions as metabolic sensors. Moreover the relationship between orphan receptors and various metabolic disorders that are now collectively called Syndrome X was unveiled. Syndrome X is lifestyle related health disorders including obesity, diabetes, hyperlipidemia, hypertension, and atherosclerosis. Orphan receptors also act as defense sensors against xeno-and endobiotics, for their target genes include drug and xenobiotic chemical metabolic enzymes (cytochromes P-450) and transporters. The nuclear receptors and Syndrome X offer a wide range of chemical computing and bioinformatics research topics: receptor modeling, ligand-receptor docking, interaction of DNA and receptor dimer complex, identification of target genes, cis-regulatory elements, product proteins, and the resultant pathways/networks, and modeling and simulation of the pancreatic beta-cell, adipocyte, insulin signaling, and obesity. The author reviews the state-of-the-art of nuclear receptor and Syndrome X research from chemical computing and bioinformatics viewpoint, and proposes a project, called Nuclear Receptor and Syndrome X (NR-SX) Project, which is a possible killer application of chemical computing and bioinformatics in the genomic era.
Introduction
The completion of the Human Genome Project was declared in April of this year, as if to celebrate the 50th anniversary of the publication of the famous Watson-Click's Nature paper on the DNA structure. Already a new vision for future genomic research was proposed, and the project was decided to be continued [1] . Since the project has influenced diverse biomedical research areas, topics have been discussed in many related areas, such as how to set the new goals and innovate the research style by taking the results of the genomic research and its related technologies into account. Bioinformatics is not an exception. Current bioinformatics started as a research discipline of applying computer technologies (IT) to sequencing technologies. Modern biology started when molecular biology was born. Molecular biologists have wanted to understand biological systems in terms of chemistry, therefore chemical computing has been considered as one of the basic tools in molecular biology from the very beginning. As molecular biology and related sciences have increasingly depended on knowledge of genes and the resultant proteins, the roles of computing and informatics have ever increased, for both genes and proteins are characteristically strings that can be represented by symbolic codes. Symbolic codes and strings are familiar entities that can be processed by computers. Since chemical computing became an indispensable research tool for studying nucleotide and protein structures, the borderline between chemical computing and bioinformatics are not so clear today. For example, these two disciplines are used in an inter-mixed way for investigating the protein folding problem.
So what are the new goals of bioinformatics and its partner chemical computing in the coming genomic era, and what are the attractive themes and challenging projects in these fields? A new perspective is to focus human resources and the potential power of computing on some influential fields, and enhance the autonomy and status of computing and informatics researchers in biology and related sciences. Nuclear receptors and Syndrome X are two most promising application areas in this perspective. In this paper, the sate-of-the-art of nuclear receptors and Syndrome X research are reviewed from chemical computing and bioinformatics viewpoints, and a project called, the Nuclear Receptor-Syndrome X (NR-SX) Project, is proposed in order to recruit a large number of researchers in chemical computing and bioinformatics to investigate various computing and informatics problems in these two biomedical research areas. The project will give great impacts on these areas, and will become a killer application of computing and informatics methods in the genomic era. Physiology, etiology, toxicology, pharmacology, and drug discovery contain this problem that must be challenged by genome-based approaches. Therefore, methods for integrating different "genome (cell) worlds" and construct "trans-genomic models" for multi-organisms are the fundamental problem to be solved for future bioinformatics research. Since not even the gene regulation mechanism in a single cell is completely understood, the above problem is difficult to solve in a systematic and comprehensive manner used in the Human Genome Project.
An alternative approach is to mix systematic, computational, algorithmic, and equation oriented methods with ad hoc, knowledge-based, heuristic, and descriptive methods. Neither single discipline nor method is sufficient to solve the trans-genomic problems, and informatics or computing researchers should collaborate more closely if they want to contribute in this arena with their own initiatives. Moreover, they must choose appropriate areas and themes if they want to take an initiative. One of the premises for this selection is that the themes are suitable for theoretical and computational approach and that the results are relevant for biomedical research.
Nuclear receptors and Syndrome X are very attractive in this viewpoint since this area is where intensive experimental researches are ongoing and where a large amount of data and knowledge relevant to theoretical and computational approaches has already accumulated. If many researchers in chemical computing and bioinformactics could be recruited to these fields, and if they are orchestrated to well defined goals, they may make big contributions to the progress of studies in these fields. Such a collaborative work will become a paradigm for the new bioinformatics research in the genomic era.
Significance of Nuclear Receptor Research
Nuclear receptors form a superfamily of proteins, which consists of 50-60 proteins in case of humans (Table 1) . They were first discovered as receptors for steroid and thyroid hormones, and retinoid acid [19] . Nuclear receptors whose ligands were unknown were cloned thereafter and were named orphan nuclear receptors. Recently, many such orphan receptor ligands have been identified and their essential roles in energy metabolisms are discovered [20] [21] [22] .
Hormonal receptors such as estrogen receptors, androgen receptors, progesterone receptors, thyroid hormone receptors, retinoic acid receptors, and vitamin D receptors are apparently related to sex hormone related disorders, such as breast and prostate cancers, thyroid disease, and developmental and morphological disorders. They are also related to anti-aging syndromes, including osteoporosis, and are subjects of the hormone replacement therapy (HRT) for postmenopausal women. Another important significance of hormonal receptors is the endocrine disruptor problem. The endocrine disruptors are chemical contaminants that act on and disturb endocrine systems, are suspected for affecting biological systems by binding to some of these hormonal nuclear receptors [23] [24] . The significance of orphan receptors was uncovered when those receptors were found to function as lipid sensors and contribute to lipid and energy balancing. Lipid and energy imbalance causes many serious health disorders such as obesity, diabetes, hypertension, atherosclerosis, and gallbladder disease. Active research was conducted when certain diabetes drugs were found to bind to one of the orphan (but now adopted) nuclear receptors, PPARs. Orphan receptors are now studied aiming to find new therapeutic agents for the so-called lifestyle or adult diseases, which are now called by more collective and mysterious term "Syndrome X" [25] [26] .
Orphan nuclear receptors are also significant for the fact that target genes of these receptors include genes for drug and xenobiotic metabolic enzymes (cytochromes P-450, CYPs) and transporters [27] Table 2 ). This is related to the function of the orphan nuclear receptors as sensors not only for endogenous energy metabolites but also for exogenous nutrients and environmental contaminants. Particularly, ligand-activated PXR induces CYP3A4, which is responsible for the metabolism of more than half of current drugs on the market. Similarly, CAR induces the CYP2B subfamily, which metabolizes xenobiotic chemicals in the environment. The drugs that bind to PXR may interact with many other drugs when simultaneously prescribed for regimen. Thus it is more desirable to design a new drug that does not induce PXR activities. Such drug-drug consideration equally applies to drug-food, or drug-xenobiotic chemical interaction via CAR. Thus drug designers should routinely check the binding capability of their drugs to PXR or CAR. This is a new research branch that is not yet well recognized among drug designers. Recently, X-ray crystallography data were obtained for a human CYP [33] . These data may stimulate computer modeling of CYP proteins. Figure 1 summarizes the significance of nuclear receptor research. The common and core research subject is identification of pathways and networks of nuclear receptors, for pathways and networks are directly related to the action mechanism of nuclear receptors. How ligands, that is, endogenous ligands, synthetic agonists, and antagonist, modulate the pathways and networks is the heart of drug discovery, drug-drug interaction, and environmental toxicology. The ligand-binding domains of nuclear receptors have a similar structure, and X-ray crystallography data have been Table 2 . Relationship between nuclear receptors, drug metablic enzymes, and transporters
The target genes of nuclear receptors include genes for cytochromes P-450 (CYPs) and transporters. [39] . Such docking studies are discussed in a later section. More than half of the present drugs were designed for target membrane receptors, while only a small percent are for nuclear receptors. In this sense, nuclear receptors are a minor target in drug discovery research. However, prevalence of obesity or diabetes in developed countries make these drugs very important from social and commercial viewpoints. Nuclear receptor research is also important from genome research viewpoints, since they function as ligand-activated transcription factors. Ligand-bound nuclear receptors form a homo-to hetero-dimers, to which tissue specific cofactors bind and form a more complex structure, which then binds to a specific DNA sequence called the response element. This binding either activates or represses target genes. This regulatory mechanism and the target genes are not yet fully understood. Understanding gene regulation mechanisms is one of the most important genome research themes after the completion of genome sequencing, so that identifying target genes, their complete cis-regulatory elements, and cofactors of nuclear receptors, and understanding the regulatory mechanisms are important not only for nuclear receptor research but also for genomics research.
NR

Computational and informatics approach to nuclear receptors
There already exist many chemical computing and bioinformatics works that contribute to nuclear receptor research. We will investigate some of these works and discuss new frontiers. The past and future works are categorized into three classes, (1) data and knowledge storage, data analyses and mining, and knowledge manipulation, (2) molecular modeling and energy calculation, and (3) system modeling and dynamical simulation.
Information and Databases in the Public
As mentioned above, all nuclear receptors function as ligand-activated transcriptional factors. Ligand-bound nuclear receptors form hetero-or homo-dimers that recognize specific DNA sequence regions. Before forming a dimer 90-kDa, a heat-shock protein (HSP90) that has bound to a nuclear receptor detaches form the receptor, suggesting that nuclear receptors have ligand biding domain (E domain) and DNA binding domain (C domain). In addition, a nuclear receptor has (1) an amino-terminal domain called the A/B domain, which varies in amino acid sequence length, bears immunogenicity, and contains the ligand-independent transcription activation factor (AF-1), (2) D domain, and (3) the carboxy-terminal domain F. HSP90 binds to the intermediate sequence between domains C and D (Figure 2 ).
There are already various nuclear receptor databases open to the public that contain classification, nomenclatures, gene and amino acid sequences, domain structures, and gene loci of nuclear receptors on the chromosomes [40] . The three-dimensional structure data of the ligand-binding domain were obtained for several nuclear receptors including estrogen receptors, vitamin D receptors, PXR, and glucocorticoid receptors by X-ray crystallography. Some of the data are available from PDB. Almost all nuclear receptors share certain three-dimensional structure features in their ligand-binding domains. Crystallogaphy identified the zinc-finger motif of DNA binding structure, and the complex structures of the ligand-bound receptors, which are in dimer forms, and DNA sequence fragments. In addition to these basic structural data, there are a wide range of nuclear resource sites that can give further useful and detailed data and knowledge for more specialized fields. These affluent public domain data and knowledge are grounds for chemical computing and bioinformatics approach.
More Dedicated Data and Knowledge Base for Nuclear Receptors
Although the aforementioned mentioned public databases provide a wide range of basic data and knowledge on nuclear receptors, they are not coordinated nor systematized enough for people to comprehend the over all features of genetic codes, linear and three dimensional structures, and functions of nuclear receptors. Especially, if one wants to study these relationships in the framework of physiology, etiology, health disorders, drug discovery, personalized medicine (optimal regimen), and food science, the existing databases of general purposes have limited values. Several groups, research communities and consortiums are constructing more goal-oriented and detailed websites and databases. A database of nuclear hormone receptors, NUREBASE [41] , a project for collecting distributed database of nuclear receptors, the Nuclear Receptor Resource (NRR) Project [42] , and a research community for nuclear receptors and metabolic disorders, the Nuclear Receptor Signaling Atlas (NURSA) [43] are such examples.
The author and his collaborators are also developing a website and database of nuclear receptors [40] . The goal of the website is to develop a portal of nuclear receptor research, particularly for enhancing collaboration between experimentalists and computing and informatics researchers, and the goal of the database is to find the links between nuclear receptors and their related molecules to investigate their relations easily and interactively using schematic diagrams.
Protein modeling and docking study
Studies on three-dimensional structures of ligand-binding domains and ligand-bound receptor complexes have been conducted for nuclear hormone receptors including estrogen receptors, androgen receptor, vitamin D receptor, and glucocorticoid receptor. Among these, estrogen receptors were most well studied, for there exist crystallography data and they are the targets of breast cancer therapy ( Figure 3 ). These drugs, which are called selective estrogen receptor modulators (SERMs), modulate the estrogen receptor pathways. These receptors are also targets of the environmental chemical contaminants called endocrine disruptors.
There exist a large number of computer-based docking studies on hormonal ligands and the ligand binding domain of the receptors [44] [50] . Such a model calculation starts by building a ligand-binding domain modeling. Since the crystallography data do not give the coordinates of hydrogen atoms, the first task is to identified these coordinates by some modeling method. Then, overall structure should be refined by some approximate quantum mechanical calculation. Finally, hydrogen bonds between certain amino acid residues of the domain (protein) and the ligand should be identified using docking modeling. Since there are over 200 amino acid residues in such a domain, exact ab initio quantum mechanical calculation is inapplicable. Recently, a very powerful new approximation method, the ab initio fragment molecular orbital (FMO) method, was developed [51] [52] and has been successfully applied to solve this problem [53] . In case of flexible docking, further adjustment of the overall complex structure is needed by some optimization algorithm. The minimum binding energy of such a model gives an insight into the binding affinity of the ligand and the receptor. However, because potential energy is arbitrary, the absolute values of the energy calculation is meaningless and such calculation is effective only for comparing relative binding strength to a domain protein between two or more ligands.
Experimental data on relative binding affinity are useful for checking the results of such model calculations. A database of chemicals that bind to a receptor is called a focused library. There are databases of receptors for drug and environmental chemicals. Such databases were developed by the author's group and were made available for the public [54] [55] [56] . These three databases is preferably integrated for systematic docking study.
DNA sequence recognition and cis-regulatory elements
The binding mechanism of a ligand-bound receptor dimer to a specific DNA sequence region called the response element has been studied based on structure data from X-ray crystallography and Nuclear Magnetic Resonance (NMR) ( Figure 4 ). This is an example of a more general problem of DNA-protein interaction. The characteristics of DNA sequence and the motifs of binding proteins have been studied experimentally and theoretically. For example Sarai has developed databases and algorithms to predict the target sequences of transcription factors [57] . In case of nuclear receptors, particularly hormone receptors such as estrogen, thyroid, retinoic acid, and glucocorticoid receptors, the DNA-binding domains are highly homologous and structurally similar, and have two distinct zinc fingers consisting of eight cysteine residues. The binding and unbinding mechanisms of the DNA-binding domain and the response element have been studied using The response element to which ligand-bound receptor dimer binds is on the promoter of the target genes of nuclear receptors. The response element of the non-steroid receptors such as thyroid hormone receptor, retinoic acid receptor, RXR, vitamin D receptor, PPAR, and ecdysteroid receptor share the same AGGTCA hexad of the estrogen response element. While the two hexads of the steroid receptor has a palindromic configuration that is separated by three nucleotides, the hexads of the non-steroids are direct repeats separated by one to five nucleotides [19] . However, there are many variations in this common configuration giving much flexibility to gene regulation. The flexibility also give a basis of interferences and cross-talks among gene regulatory signals [60] [61] .
If the binding is very tight, and if we can identify the specific DNA sequence (response element) to which a given protein complex binds by some model calculation, it may be possible to identify all cis-regulatory elements of some genes solely by computation. However this is not the case, for the recognition of the DNA sequence by a receptor complex is not so strict and more than one consensus sequences (response elements) are recognized by a given receptor complex. Nevertheless, since a response element is on the promoter region of a (receptor target) gene, such calculation is effective for predicting cis-regulatory elements in a systematic way. The prediction is one of the most important experimental and theoretic themes in the genomic era [62] [63] . In order to identify cis-regulatory elements, the chromatin immunoprecipitation assay is used in experimental studies. For theoretical prediction, several algorithms including hidden Markov model are applied [64] [65][66] [67] .
The molecular dynamics approach and bioinformatics algorithmic approach are mutually complementary, for the on/off switch mechanism of the DNA-binding domain and the response element is not pure binary. If the molecular dynamics calculation can estimate affinity more exactly, that estimation value can be incorporated into bioinformatics algorithms, which may give better prediction on the cis-regulatory elements.
There is another class of proteins that play very important roles in gene regulation of nuclear receptors. They are cofactors, or co-activators and co-repressors. These factors work synergistically with ligand-activated receptor dimer complex, and regulate on/off switching of gene regulation. Although many of them are already found, there should be more to be discovered. The cofactors also determine tissue specificity of gene expressions, and are mediators for signal cross-talks. Since the members and functions of cofactors are not yet identified, making models for these and other factors is left as a future theme.
Target gene identification
Already a large number of genes have been identified as the target genes of nuclear receptors, and experimental efforts are continued to find a complete list of such genes. In fact, one goal of NURSA is to find new target genes of orphan (metabolic) nuclear receptors [43] . Since such target genes and their products (proteins) may be intrinsically related to metabolic syndromes, they are also possible putative therapeutic drug targets. Pure computational approach is a very difficult task even when the complete genome sequence is available, yet some projects have been proposed towards this goal [68] . The target gene identification problem is closely related to identification of cis-regulatory elements, because identifying one sequence unit enables the other sequence unit to be reasoned by associating target genes and their cis-regulatory elements. Such an approach becomes possible only after the complete human genome sequence data is available, and we can say that this type of problem will be truly a computational theme in the genomic era.
Pathways, networks, and their cross-talks
Signal flow of a nuclear receptor starts by the receptor binding with the ligand, releasing HSP90, and forming a dimer with another same or a different receptor, and the resultant dimer binding to the response element, expressing the target gene, and synthesizing and activating the protein. The process involve the formation of the autocrine feed back loop, which goes back to the original ligands by metabolism ( Figure 5 ).
Three additional features should be added to this rather simple picture. First is gene-gene interaction among nuclear receptor genes through transcription. For example, LXR induces itself, and it is also induced by PPAR. If we have the complete list of target genes, we can easily predict such gene regulatory networks, but at this moment, only parts of such networks are known. Second Either endogenous or exogenous ligands bind to the nuclear receptor complexes that dissociate the heat shock proteins, HSP90s, and other components upon ligand binding. A ligand-bound receptor form a homo-or hetero-dimmer complex that recognizes a specific DNA sequence called response element. Their target genes include the genes for the nuclear receptors themselves, metabolic enzymes, and transporters. The auto-regulated nuclear receptors may trigger further gene expression, and the metabolic enzymes may metabolize the input ligands. In addition to this feedback loop, there exist several pathways in the membrane receptors that cross-talk with the ligand-activated nuclear receptor pathway.
feature is the action of metabolic proteins that are coded by some target genes. Since target genes of orphan nuclear receptors contain metabolic enzymes such as cytchromes P-450 (CYPs) and transporters, original ligands are either metabolized or transported by the induced enzymes as the result of their own actions. Third factor is signal cross-talks, which is possibly caused by mutual interference between the actions of two or more different receptors via transcriptional interference, in which two ligand-activated receptors can recognize a same response element. There is another possible cause of signal cross-talks, which is nuclear receptor signals cross talking with other signals from different kind of receptors. For example, endogenous estrogens bind to a membrane receptor as well as to a nuclear receptor, and there is a signal cross-talk between these two signals [69] [70] . This means that one must consider metabolic pathways, cell signal transductions, and gene regulations if he or she wants to have a complete image of nuclear receptor signals and networks.
The pathways and networks of nuclear receptors are the core knowledge for disease modeling and drug discovery. However, what the experimentalists really need is not only the map but also the traffic record. Signal flows have organ, tissue and cell specificity, which also depends on time and environment. A realistic approach is to start form a simple description of the entire image, and refine the picture as experimental facts are accumulated. Such a model may not be reliable forprediction, but it should be yet useful for compiling experimental facts as references.
Molecular pathways/networks to Syndrome X
Over view
Syndrome X or "metabolic syndrome X" refers to a group of health disorders that include overweight (obesity), insulin resistance (type 2 diabetes), abnormal blood fats (hyperlipedimea), high blood pressure (hypertension), and many other age-related disorders such as atherosclerosis, eye disease, cancer, and Alzheimer's disease. These syndromes are deeply related to personal lifestyle, and they are collectively called "Life-style Related Diseases (Seikatsu-shukan-byo)" in Japanese. Since population suffering Syndrome X is rapidly increasing in developed countries, these diseases have attracted social attention, and became one of the focused areas in the current health sciences and the target of preventive medicine campaigns.
Because they are metabolic disorders, Syndrome X disorders are deeply interrelated to each other. Extensive studies have been carried out to find common key molecules for these disorders [71] . For example, insulin and leptin are two of such molecules involved in both obesity and diabetes, and resistin is another candidate. Fats and glucose derived from exogenous nutrients are also key molecules.
Recently, orphan nuclear receptors are noticed in this research arena, for they are master regulators controlling the metabolisms of (1) energy and glucose (PPARγ), (2) fatty acids, triglycerides, and lipoproteins (PPARα, β/δ, γ), (3) cholesterol transport (LXR and LRH-1), (4) bile acids (FXR, LXRs, LRH-1), and (5) the defense against xenobiotics and endobiotics (PXR/SXR) [72] . Imbalance in these metabolisms causes Syndrome X disorders, thus these nuclear receptors are studied as putative targets for developing therapeutic drugs of metabolic disorders. While there are multiple factors that lower fat and lipid levels in the body, insulin is the only endogenous factor for lowering glucose level, and the pancreatic beta cells are the only endogenous source of insulin.
Risk factors for Syndrome X are classified into three categories; (1) genetic factors that are increasingly expressed as aging, (2) life style such as diet, exercise, alcohol, and smocking, and (3) environmental exposure to pathogens, contaminant chemicals, and physical disturbances such as radiation including sunshine. Among obesity, hypertension, hyperlipidemia, and hyperglycemia are considered to be the primary disorders while insulin resistance (type 2 diabetes), cardiovascular diseases such as atherosclerosis, and brain stroke are secondary chronicle illness. Diabetes further triggers eye and renal disorders.
Syndrome X disorders are related with each other via either transcriptional regulation through orphan nuclear receptors or via non-transcriptional signal transduction pathways. Moreover, since there are many cross-talks between signal pathways that are related to different class of nuclear receptors, health disorders that is caused by the perturbation of these two pathways are especially related to each other. For example, Syndrome X disorders are related to aging disorders caused by the lack of steroid hormones, such as estrogen in postmenopausal women. Estrogen is protective against vascular and bone (osteoporosis) disorders. Although details of the mechanism are not yet known, the interdependence among these disorders via common key signal molecules are already well illustrated.
Approaches to modeling
Two complementary approaches are effective candidates for modeling Syndrome X: top down and bottom up. The top down approach starts from physiological models, which are prepared using classical physiological and organ level parameters, and goes to single cell level models. The bottom up approach starts from single cell models of organs such as pancreas, liver, gastro intestine, skeletal muscle, blood vessels, etc, and goes to classical physiological models. Advances in genome-wide simultaneous measurement techniques, various-omics technologies such as trancriptomics (gene chip or microarray), proteiomics, and metabolomics/metabonomics give theoretical researchers a hope to build a cell model with the complete molecular pathways and networks within the cell. Such an approach seems feasible for singe cell organisms such as bacteria and yeast [73] .
However, in case of more complicated multi-cellular organisms including humans, each cell has its own characteristic feature according to the tissue specificity, and its gene expressions, proteomes, and metabolites vary depending on cell. Ideally, different molecular pathways and networks models should be developed for each tissue and organ cell. If we can connect these individual cell models and the pathways and networks, we will be able to develop an integrative pathways/networks model, which can further be tailored into a physiological or etiological model for each syndrome and disease. However, for the latter model, we must explicitly take time factors into consideration, because disease is not static in nature and will change as time goes on. Therefore, although the eventual goal of Syndrome X modeling is to integrate the top down and bottom up approaches, it is unrealistic to pursue the pathways/networks models straightforwardly. An alternative approach that is more realistic and useful, especially in clinical practice, is to develop the following models of various levels and integrate them in a heuristic manner: (1) physiological and etiological model, (2) molecular pathways/networks model, and (3) specific cellular model. Such an approach was first proposed by the author using C. elegans as a model [74] . Now various research groups including many start up bioinformatics companies are proposing models of "pathways/networks that may cause diseases". [75] .
Concerning Syndrome X insulin secretion and its signaling are examples of well studied physiological models [76] . On the contrary, obesity modeling is still immature at least to the public, for the concept and mechanism of obesity as a disease was poorly understood until very recently. The pivotal discovery was made when adipocyte was found to be not a mere deposit tissue for energy (fat) but an endocrine-like system that secretes various hormonal factors called adipocytokines or simply adipokines [77] . This discovery together with advances in orphan nuclear receptor research that unveiled their roles in energy metabolism and characterization of adipocytokines provided a better knowledge background for constructing a theoretical and computational obesity model.
A molecular pathways/networks model for Syndrome X consists of ligand-binding actions to metabolic nuclear receptors, DNA binding of ligand-activated nuclear receptor complexes that trigger target gene expressions, autocrine (feedback) and parcrine action of post-translational proteins of these expressed genes, and their cross-talks with other signal transductions. In order to make realistic pathways/networks diagrams, one must know the complete set of target genes and their expression modes and their tissue specificities. However, these goals are still investigated by many on-going experimental works, and computational and informatics approaches can at most produce limited and partially correct pictures.
Key player cells and tissues of Syndrome X are the adipose tissue (adipocyte), pancreatic (Langerhanse islets) beta cells, liver (hepatocyte), (smooth and skeltal) muscles, bile, gastro-intestine, immune system (like macrophage), vascular epithelium cells, brain, and blood. Signal molecules and molecular mediators among these tissues are nutrient metabolites such as lipids (i.e., cholesterol and trigricerid), fats and fatty acids, sugar such as glucose, and endogenous signal proteins such insulin and leptin.
It should be noted that cells in these tissues proliferate, differentiate, and die by apoptosis. Therefore tissues change their masses. Gene expressions of cells in these tissues also vary depending on time and situation. It is very difficult to model these dynamical natures of cells and tissues. In this sense the current models give only simplified pictures of real world. Some illustrative examples are given in the following sections.
Pancreatic beta-cell
If we can model the differentiation of pancreatic endocrine cells, it will be able to give us some insights of efficient conversion of human stem cells into pancreatic endocrine cells. The knowledge of this process will be useful for treating type 1 diabetes by cell replacement. Such a model will also be useful to understand the function of pancreatic beta-cell, which possibly give us some insights of therapeutics for type 2 diabetes. Experimental evidence is poor on this subject as compared to the evidence on differentiation of preadipose cells into adipose cells in obesity cases.
More promising modeling is time-dependent dynamics of insulin and glucose transport. Bergman proposed such a model and called it "minimal-model" [78] . This model has been widely used and refined by taking other factors such as free fatty acids (FFA) into account.
Glucose induced insulin secretion is another goal of informatics modeling. Since parts of the signal transductions that lead insulin secretion from pancreatic beta-cells in response to influx glucose stimulation have been identified, it is likely possible to build pathway and network model of a beta-cell using experiment data [79] [80] [81] [82] .
Modeling the effects of insulin on target tissues is another topic that now attracts many researchers ( Figure 6 ). Secreted insulin from beta-cells will be delivered to target tissues such as liver, adipose tissue, and skeletal muscles. Insulins that bind to the insulin receptors stimulate glucose transport of the target cells by translocating glucose transporters (GLUT4). Though not complete, intensive experimental studies have uncovered complicated signal transduction pathways in the target cells. The signal transductions consist of stepwise pathways from the insulin receptors to gene transcription with which many other molecules including glucose transporters and other stimulants and effectors such as FFA interact. Several research groups are working to modeling this Type 2 diabetes is characterized by the disfunction of such insulin signaling in the target cells. This disorder is called insulin resistance. Pathways/networks modeling of insulin-responsive cells will possibly give some new insights of the mechanisms of insulin resistance and will possibly enable new therapeutics for type 2 diabetes to be developed. It is interesting to note that type 2 diabetes is deeply related to obesity, and the adipose tissue somehow influences insulin sensitivity of other peripheral tissues, probably through signal molecules such as leptin, TNFα, FFA, and adiponectin [87] [88] . Thus, a single cell model for insulin signaling pathway has an intrinsic limitation in explaining the insulin resistance mechanisms.
Adipose cell
Adipocytes are cells that contain fats and have the role of energy homestasis [89] . Adipogenesis, the formation of adipocyte, is a multi-step process starting from mesenchymal cell proliferation (clonal expansion), followed by differentiation of some of these cells into preadipocytes, and subsequent differentiation of these preadipocytes into adipocytes, which are filled with lipids. These lipids first accumulate in small droplets (multilocular cells) and eventually fuse into one large droplet (unilocular cells). Adipocytes can continue to enlarge by accumulating additional lipids. In fact, the adipocyte tissue can have the largest mass in the body. Due to its pathogenesis significance on obesity and to the availability of good cell culture models, adipogenesis is one of the most intensively studied developmental processes [90] . Cell culture studies have illustrated the transcriptional cascade that promotes fat cell differentiation. Transcriptional factors that trigger this process are CCAAT/enhancer binding proteins C/EBP(α, β, γ) and PPARγ. Though detailed collaborative mechanism of these two classes of transcriptional factors are not yet unveiled, it was suggested that C/EBP(β, δ) functions in the first step while C/EBPα and PPARγ function in the second step in parallel. There are some cross-talks between mediators in the second step. A well known developmental signaling, Wnt signaling, functions as an adipogenic switch in which prevention of Wnt signaling in preadipocytes induces these cells to differentiate into adipocytes. Microarray analysis during adipogensis has been carried out, and metabolic role of LXRα was illustrated [91] . Modeling adipogenesis has now started to attract theoretical model builders [92] .
Another challenging topic for theoretical model building of adipose tissue is the production and function of diverse adipocyte-derived factors including TNF-a, adiponectin, leptin, FFA, IL-6, prostaglandin, etc (Figure 7 ). Though not yet completely understood, these factors regulate a variety of cellular processes. Among all these factors, adiponectin is attracting current research interests due to its role in diabetes. Recently, adipocyte receptors were cloned, and administration of adiponectin was found to improve insulin resistance [88] . Although functions of many of these adipocytokines are not yet fully understood, as in the case of insulin, methods for modeling the mechanism of secretion and action of these adipocytokines are very attractive future topics in bioinformatics.
Other cell models
There are more tissues and organs whose cells should be modeled in the same way. Among them, the liver and vascular systems are likely to be most important. Recent advent of microarry and proteomics has supplied large amounts of data that are useful for such works. However, at this time, our knowledge on pathways and networks of hepatocyte or vascular cells such as endothelial and smooth muscle cells are not so affluent as compared to that of beta cell or adipocyte; and realistic modeling of the former seems to be too early to work with.
Integrative modeling for Syndrome X
The intermediate goal of theoretical modeling for Syndrome X is to construct an integrative model that can explain obesity and diabetes, and to extend the model so that it can explain other disorders such as hypertension, hyperlipidemia, and atherosclerosis. Such a model must take various key molecular players into account.
The start-up model should be a compartment model. The basic compartments are the circulating blood, gastro intestine, liver, pancreas, adipose tissue, muscle, bile, and other tissues. The input and output factors of these compartments are nutritional and energy compounds such as amino acids, sugars (i.e., glucose), lipids (i.e., fatty acids), and their mixtures (i.e., triacylglycerol), and signaling molecules such as insulin. Balance among these factors can be described by a set of equations. Such a classical physiological model is the basis of the pathways/networks in obesity and diabetes model. Some intracellular pathways should be explicitly considered to develop a more sophisticated model.
One characteristic feature of type 2 diabetes mellitus is insulin resistance. Therefore, one must consider insulin signaling pathways in the insulin effecter cells, if he or she wants a more fine model [76] . Although the complete picture of this signal pathways is still unveiled, some molecular players and pathways have been identified. Such molecules are PPARα and its agonists, RXR and its agonists, beta 3 Adrenergic Receptor (β 3 AR) and its agonists, Protein Tyrosine Phosphatase-1B (PTP-1B) and its inhibitors, and Glycogen Sythase Kinase-3 (GSK-3) and its inhibitors as well as ubiquitous circulating signal molecules, such as insulin and fatty acids and their receptors and transporters on the cell membrane. Pathways of mitochondria inside these cells must also be considered. Pancreatic beta cell ( the insulin source) and adipocyte (the fat source) should also be incorporated into the model. One of the goals of such modeling is modeling obesity. Figure 8 gives a very simplified picture of the mechanism of energy control, including key organs and key signaling molecules. Though a large volume of relevant data and facts are accumulated in the past decade, the true mechanism of obesity is not yet fully understood. However step-by-step effort to refine this kind of picture will eventually unveil the secret. For the time being, even a rough sketch model may be effective since obesity is not yet fully understood.
Step-by-step effort to refine this kind of picture will help gaining some etiological insights of obesity and its related diabetes, and may give some hints for drug discovery, for only with such a model one can visualize the relationship between therapeutic agents, their action points (gate points), and their outcomes (endpoints) in a systematic cause-effect relation.
New findings in transcription regulation, genetic variation, and comparative genomics
The above models are mere simplified picture of the true biological systems. The dogmatic view in which linear DNA sequence codes (genes) are mapped to mRNA chains, which are further mapped to amino acid chains for proteins, underestimates the roles of chromatin dynamics, noncoding RNAs, and mRNA splicing, and post translation protein modifications. Recently, new experimental discoveries have cast lights on these hidden mechanisms. For example, the roles of chemical modifications including methylation, phospholilation, ubiquitination, and acetylation in relation to chromatin remodeling and the roles of small uncoding RNAs as the true master regulators of transcription regulation have been unveiled. These transcription modifications control the amount of gene expressions shown in microarray data.
It is obvious that conventional bioinformatics methods, which are based on linear codes, cannot explain such a dynamic phenomenon. Conventional bioinformatics models of pathways and networks are based on binary (switch on/off) representations. From a causal viewpoint, such representations often give a contradictory image of the subject system. Such contradiction can only be resolved if we take quantitative factors and time factors into consideration. For example, it is very difficult to understand the auto-induction of nuclear receptors in a binary picture. It was suggested that the difference in binding affinity of ligand-bound receptor between the response element of the nuclear receptor itself and the (other) target genes possibly explains the mechanism. This means that there are only low concentrations of ligands at the beginning, which only induce the nuclear receptors; however in later stages, when there are a large amount of ligands, the nuclear receptors induce their target genes. More quantitative and integrative approaches that explicitly take dynamic nature of the reactions into account must be developed in the future.
Another factor that should always be considered is genetic variation. Finding the susceptible genes for common complex disease is still a difficult task even in the genomic era. Nevertheless, we already have an accumulation of a large volume of data on sequence variation including SNPs. SNP and other genetic variation data, which were obtained as a part of genome sequence projects, can be mapped to the model pathways and networks. Phenotype-genotype analyses using model animals give valuable information. The significance of genetic variations and candidate genes for health disorders will be able to be understood if we map these data to the model pathways/networks and elucidate their influence on the context of pathway/network perturbation. Such consideration will possibly give insights into the etiology of the disease. There is an excellent work for modeling hypertension that used genetic variation of model animals [93] .
Comparative genomics is a new research field opened by genome sequencing with bioinformatics. One important application of comparative genomics is comparison of genes and proteins between model animals such as rodents and humans. Such analyses may reveal how animal experiments can be extrapolated to humans. Another application is to investigate evolutional changes in the functions of proteins. The same protein in different organisms may function differently. For example, the function of leptin changed in a certain stage of evolution [94] . Such analyses became important for drug discovery, and are now named pharmacophylgenomics [95] .
Search for therapeutic agents
Nuclear receptors are attractive targets of therapeutic agent. Breast cancer drug tamoxifen and raloxifene are famous selective estrogen receptor modulators (SERMs). Orphan receptors are therapeutic targets for obesity and diabetes. Type 2 diabetes drugs, thiazolidinediones and their derivatives, are agonist of PPAR γ [96] .
Nuclear receptors are also targets of natural products and food ingredients. Phytoestrogen such as genistein in soybean is a well known natural product that binds to and activates the estrogen receptor. The phytochemical resveratrol, which is found in grapes and wine and has various anti-inflammatory, anti-platelet, and anti-carcinogenic effects, is an agonist for the estrogen receptor [97] . A widely used herbal remedy for depression, St. John's wort, has a psychoactive constituent hyperform that activates PXR [98] . Conjugated linoleic acid (CLA) is a popular dietary supplement that is believed to have beneficial properties for Syndrome X [99] . Some researchers hypothesize that CLA cause its positive effects on diabetes by regulating gene expression via binding to PPARs. One isomer of CLA decreases glucose and lipid uptake and oxidation and preadipocyte differentiation by altering preadipocyte gene transcription in a manner that appeared to be due, in part, to decreased PPARγexpression.
These are but few examples of the agents whose targets are nuclear receptors. This is a rich and important area not only for drug discovery but also for supplement research and the so called functional food research.
Extension to other ligand-activated transcription factors
The concept of these approaches and the information and computing platforms that will be developed for nuclear receptors and Syndrome X will also be useful to solve problems in other areas. The closest and most promising area besides nuclear receptors is the ligand-activated transcription factors. One example is aryl hydrocarbon receptor (AhR), which is known as the target of chemical pollutants including dioxins, i.e., 2,3,7,8-tetrachlorodibenzo-p-dioxin [100] . Dioxin-activated AhR forms a hetrodimer with the AhR nuclear translocator (Arnt), binds to a xenobiotic-responsive enhancer (XRE), and induces CYP1A1. There is a report that suggested a correlation between diabetes and high dioxin blood concentration [101] . If this is true, it is conceivable that diabetes and dioxin disorders interfere with each other through some cross-talks between the pathway via AhR and the pathways via orphan receptors, including PPAR, or other hormonal receptors like estrogen receptors. Recently, it was discovered that dioxins can mimic the effects of estrogen, and a cross-talk mechanism between the AhR pathway and estrogen pathway was illustrated [102] . It is further suggested that the AhR may be activated by natural ligands and interact with estrogen receptors.
NF-κB is another example [103] [104] [105] [106] [107] . The NF-κB family proteins are multi-functional, and are involved in immune and inflammation response, cell survival, and proliferation. Many cancers exhibit disturbances in signal pathways that activate the NF-κB protein. This protein family is also known as key molecules in angiogenesis. It is suggested that NF-κB pathways interfere with pathways of Syndrome X. Although this is one of the hot spots in biomedical research, more knowledge should be accumulated before realistic pathway models can be constructed.
A perspective of the project
The goals
The author is currently proposing a project to the fellow members of the Chem-Bio Informatics (CBI) Society in order to organize a research team to investigate to the themes described in this paper. The goals of the project, which is called the Nuclear Receptor and Syndrome X (NR-SX) Project, are:
(1) to build a portal website as a base for searching, accumulating, and exchanging information, knowledge, and data for nuclear receptor studies and Syndrome X research, (2) to develop methodology and program codes for large-scale molecular computing that is relevant for protein modeling, (3) to develop methodology and program code that are relevant for docking studies of molecular-molecular interactions such as ligand nuclear receptor binding, ligand-activated nuclear receptor complexes that bind to specific DNA sequence, and cytochrome P-450 and substrate binding, (4) to develop bioinformatics methodology for identifying complete target genes of nuclear receptors and their cis-regulatory elements, and elucidate pathways and networks that are essential for understanding the wide range of actions of the nuclear receptors, and (5) to develop cell models and integrative simulation models for Syndrome X based on pathways/networks. At least several tens of researchers are needed to start this project and several hundred of researchers are need for fully deploying the subjects. This number is for theoretical and computation researchers only and does not include experimental groups.
How to achieve the goal
As stated in the above agenda, the first step of this project is to build a website on the CBI Society Home Page and provide relevant information that enables its member researchers to participate in the project, and share information, data, tools, and products with fellow researchers in the project. The open database and knowledge base should be designed so as to be used not only by theoretical and computing researchers, but also intensively by researchers in experiment field. Although the theoretical and computational specialists should take the initiative of the project, good collaboration with experimental researchers is undoubtedly a key for the success of the project. There already exist research initiatives by experimentalist to form consortium on nuclear receptors [43] , beta-cell biology [108] , and type 2 diabetes [109] ; it is worthwhile to make contacts with such groups.
An important consideration of the project from the viewpoint of management is that it should be scalable so that it can be started with few people and increase the number of participants without drastically changing its management style and structure. Second consideration is educating participating researchers. Currently, the number of researchers needed for this project is beyond the supply of current Japanese human research resource. This means that the project must have some educational or training program to cultivate talented people by its own.. At present, there are only several universities that have formal undergraduate/graduate bioinformatics courses in Japan. The CBI Society, which has a nearly quarter century experience of chemical computing and bioinformatics education, may function as a relevant support body for facilitating such training and educational activities. Another important management consideration is to establish smooth collaboration with other researchers who are in experimental fields or in overseas.
The last but undoubtedly the most important consideration is obtaining research funds. The scope of this project is too wide to apply to some grants as a single project. Moreover, it may be very difficult to comprehend this project as an unified research topic in a certain field. Hence the most reasonable strategy is to decompose the project themes and bundle them into pieces of research topics, for each of which member researchers apply to grant systems where they have their own strength.
Conclusions
The state-of-the-art of nuclear receptor research was reviewed with chemical computing and bioinformatics application in mind. The nuclear receptors are related to the endocrine hormone system, the energy metabolism, and the drug and xenobiotic metabolism and transport. From the viewpoint of drug discovery, hormone nuclear receptors are the targets of therapeutic agents for hormonal disorders including breast and prostate cancers. Some of the hormonal drugs are used in hormone replacement therapy for postmenopausal women, but the mechanisms of the beneficial and risk actions of these drugs are not yet fully understood. These mechanisms are also related to health disorders caused by the so-called endocrine disruptors. Orphan nuclear receptors are targets of therapeutic agents for Syndrome X, such as obesity and diabetes. Since activated orphan receptors induce transporters and metabolic enzymes for drug and dietary chemicals, they have important roles in drug-drug, drug-supplement, and drug-food interactions In short, nuclear receptors will be essential in current biomedicine, drug discovery, toxicology, environmental health science, food science and preventive medicine.
Although functions of nuclear receptors are very diverse, their action schemes are very similar, for they are ligand-activated transcription factors. An objective of nuclear receptor research is to identify all target genes and their regulatory elements, and understand the mechanism of gene regulation. Advances in genome research are helping experimental researchers to pursuit this problem effectively, but computational methods developed for elucidating target genes and their regulatory elements will also contribute to solving this problem. These facts together with emerging new experimental methods, such as the immunoprecipitation assays and RNA interference, give the logical base: this is a fruitful field for computing and informatics researchers in which they can make approaches of paradigmatic killer application in chemical computing and bioinformatics in the coming genomic era.
This application includes a wide range of computational and informatics research topics including protein modeling, ligand-receptor docking simulation, interaction of protein and DNA, algorithms for gene and cis-element elucidation, pathways/networks, cell modeling, dynamical simulation, integrative modeling, and many others. Among these, the elucidation of pathways and networks is the central theme and should start from ligand-activation of nuclear receptors. In the past three decades, the computational approach to biomedicine, which is now called computational chemistry and bioinformatics, has greatly contributed to the advances of molecular biology and biomedicine, yet experimentalists consider these methodologies are mere convenient tools in their fields. This is partly due to the way the theoretical and computing specialist have work for, for they have usually worked separately and their goals have not been coordinated. More coordinated strategic approach under their own initiatives is needed if computing and informatics researchers want to take initiatives and give significant contributions in these fields.
A project that aims to recruit a large number of theoretical and computation specialists to nuclear receptors and Syndrome X research is proposed in this paper in order to raise the status and effectiveness of these disciplines. The call for participating to this project is addressed to all Chem-Bio Informatics Society members. Already the start up website and the prototype systems are under construction with the collaboration of the several members of the Society including the author.
